EU Guidance / Q&A. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin
|
|
- Charla White
- 5 years ago
- Views:
Transcription
1 EU Guidance / Q&A Greg McGurk, GMP Manager (acting) GMP Conference 7 February 2017 Dublin
2 TPN Manufacture Q&A
3 TPN Guidance Proposed at IWG that working group be formed to draft guidance Several adverse events associated with total parenteral nutrition (TPN) manufacture in various EU member states which have resulted in patient harm or in some instances patient deaths
4 TPN Guidance TPN Guidance Collaborative work programme Ireland, UK, France, & Denmark Aim to provide some consistency in approach within EU
5 TPN Guidance Order receipt & Verification Minimisation of errors order entry, verification, manufacture, picking, quality checks, batch release etc Documentation batch and orders Sanitisation transfer of materials for processing VHP surface decontamination Isolators Physical controls, transfer hatches, RTPs / DPTEs,
6 TPN Guidance Area classification Environmental monitoring Controls for Manual additions Controls for automated systems Electrolyte QC Testing Process simulations / media fills Sterility testing Manufacturing process controls pooling
7 TPN Guidance Process design Visual inspection Labelling QA Release & distribution Stability Q&A document developed Awaiting guidance from GMDPIWG on next steps
8 Production of WFI through RO & Biofilm Q&A
9 Production of WFI by non-distillation method (Reverse Osmosis) Revision to WFI Monograph 169 (proposed wording) It is produced either : by distillation... by reverse osmosis, which may be single-pass or double-pass, coupled with other suitable techniques such as deionisation and/or ultrafiltration Correct operation monitoring and maintenance of the system are essential In order to ensure the appropriate quality of the water, validated procedures, in process monitoring of the electrical conductivity, and regular total organic carbon and microbial monitoring are applied
10 Production of WFI by non-distillation method Production of WFI by non-distillation (Reverse Osmosis) & Biofilm Q&A guidance document Q&A developed to take account of concerns and expectations Ireland, UK, France & Hungary Part I Production of WFI by non-distillation methods (RO)
11 Production of WFI by non-distillation method Concerns regarding production by non-distillation methods System Design considerations Control strategy; Materials of Construction; Pre-Treatment; RO Membranes; Nanotechnology; Electrodeionisation; Ultra-Filtration; TOC; Conductivity Sanitisation Qualification Sampling and testing requirements Preventative Maintenance
12 Biofilm Part II of Q&A deals more specifically with Biofilms and control strategies Overview of Biofilms and their development Control strategy Removal of established biofilm Chemical sanitising agents & Physical methods for cleaning Detectability of Biofilms
13 Q&A Production of WFI by non-distillation method (RO) & Biofilm Control Q&A developed and issued for public consultation Deadline 29th November 2016 Comments received and under review Q2 Q for finalization of draft and publication on EMA website
14 Sterilisation of Primary Packaging
15 Sterilisation of primary packaging Sterilisation of Primary packaging, used during aseptic processing of the finished product, is a critical process and the sterility of the primary container is a critical quality attribute to ensure the sterility of the finished product Not all sites performing sterilisation need be GMP certified by an EU authority Only those sites involved in terminal sterilisation of API, Excipients and finished product MIA and / or GMP certification Sites performing sterilisation of primary packaging are still expected to be named on the relevant MIA and IMP authorisations Variations to MIA and IMP Authorisations, where EU GMP certification is unavailable, to include additional supporting documentation
16 Sterilisation of primary packaging Supporting documentation for such variations: Certification that the sterilisation has been conducted and validated in accordance with the following applicable ISO standards: I.S. EN ISO Sterilization of Health Care Products - dry Heat - Requirements for the Development, Validation and Routine Control of a Sterilization Process for Medical Devices I.S. EN ISO Sterilization of Health-care Products - Ethylene Oxide - Requirements for the Development, Validation and Routine Control of a Sterilization Process for Medical Devices I.S. EN ISO Sterilization of Health Care Products - Moist Heat - Part 1: Requirements for the Development, Validation and Routine Control of a Sterilization Process for Medical Devices, and, ISO/TS Sterilization of health care products -- Moist heat I.S. EN ISO Sterilization of Health Care Products - Radiation - Part 1: Requirements for Development, Validation and Routine Control of a Sterilization Process for Medical Devices I.S. EN ISO Sterilization of Health Care Products - Radiation - Part 2: Establishing the Sterilization Dose I.S. EN ISO Sterilization of Health Care Products - Radiation - Part 3: Guidance on Dosimetric Aspects
17 Sterilisation of primary packaging Supporting Documentation: QP declaration Audit report may be requested as supporting documentation Additional points to consider: Site must satisfy themselves that the process for sterilisation and the controls in place at CMO are maintained. Validation documentation to be made available during inspection, if requested Robust system in place to confirm the sterility of the packaging components
18 Disinfectant Efficacy
19 Disinfectant Efficacy studies Leverage data from Vendor regarding initial contact times Assess various surfaces with environmental isolates Consider end of shelf-life studies In use shelf life to be assessed Grade A & B Sterile Monitoring programme Detailed SOPs for sanitisation effectiveness assessed
20 Disinfectant Efficacy studies EN 1276 / EN EN Chemical Disinfectants and Antiseptics - Quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants used in food, industrial, domestic and institutional areas Evaluation of sporicidal activity of chemical disinfectants EN 1650 / EN EN EN Evaluation of fungicidal activity of chemical disinfectants Quantitative suspension test for the evaluation of virucidal activity of chemical disinfectants and antiseptics used in human medicine Bactericidal EN Yeasticidal
21 Disinfectant Efficacy studies EN Chemical Disinfectants and Antiseptics - Quantitative non-porous surface test for the evaluation of bactericidal and/or fungicidal activity of chemical disinfectants used in food, industrial, domestic and institutional areas NOTE: there is currently no approved surface test method for sporicidal activity EN Quantitative test method for the evaluation of bactericidal and yeasticidal activity on non- porous surfaces with mechanical action employing wipes in the medical area
22 Disinfectant Efficacy studies Parameters that may be modified: Contact time Organisms Water quality Temperature Surfaces Acceptance criteria Inoculum
23 Disinfectant Efficacy studies A lower log reduction than that specified by the standards may be acceptable in practice. Acceptance criteria should be set accordingly and appropriately justified Typically EN (Surface) - Fungi - 3 log, Bacteria - 4 log EN (Suspension) - Spores 3 log USP <1072> (Surface) - Bacteria - 3 log, Spores - 2 log PDA 1 log
24 Aseptic Process Risk Assessment
25 Aseptic Process Risk Assessment Use of SMEs Include Microbiologist Round table discussions Observe & critically assess process and control measures Do not play down the severity rating
26 Aseptic Process Risk Assessment Do not increase the level of detection rating if the issue has poor or no detectability Do not decrease the probability of occurrence rating if there is a trend of the issue occurring. State the facts Use data where possible to justify It is better to identify the problem early and fix it
27 Aseptic Process Risk Assessment Environmental Monitoring does not reduce the risk Identify and acknowledge the fact that risks exist Goal is to assess those risks not to accept them Reassessment strategy
28 Questions
Overview and Introduction Annex 1 Revision
Overview and Introduction Annex 1 Revision Paul Moody, Inspector Pharmig Current Hot Topics in Pharmaceutical Microbiology, Dublin May 30 th, 2018 Scope History Process of Revision Rationale for Revision
More informationRegulatory Update. Paul Sexton. QP Forum
Regulatory Update Paul Sexton QP Forum 16 th April, 2015 Content Updates on GMP Guidance Updates on EU Legislation Draft Ph Eur monograph on WFI including RO 2 Chapter 5 - Production Paragraphs 27 to 30
More informationSchool of Pharmacy & Pharmaceutical Sciences QP Forum Thursday 16th April McGee Pharma International
School of Pharmacy & Pharmaceutical Sciences QP Forum Thursday 16th April 1 Parallel Session - Sterile Facilitator Ms Ann McGee 2 Query Topics Contamination Control Strategy Problems virtually managing
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. This document is for consultation until 11 December 2015
Ref. Ares(2015)3808922-15/09/2015 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, [date] This document is for consultation until 11
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More informationRegulatory Update. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin
Regulatory Update Greg McGurk, GMP Manager (acting) GMP Conference 7 February 2017 Dublin GMP Update Chapter 3 - Premises and Equipment (into operation since 1 March 2015) Chapter 5 - Production (into
More informationAnnex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
More informationJulie Roberts. Audit hot Topics and Regulatory Requirements
Julie Roberts Audit hot Topics and Regulatory Requirements Overview Hot Topics Examples in warning letters Tips to detecting data integrity Recent changes in regulatory requirements Hot Topics Microbial
More informationIs it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS
Is it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS Agenda Annex 1 revision why? Impact of the change on the field Conclusion The Revision
More informationWFI New Ph Eur Production Specification. Gordon Farquharson, July 2016
WFI New Ph Eur Production Specification Gordon Farquharson, July 2016 My agenda today Why this is an important debate. Pharmacopoeia updated position. The basic options available today. EP and Annex 1
More informationSubmission of comments on ' Q&A on production of WFI by non-distillation methods - RO and biofilms and control strategies' (EMA/INS/489331/2016)
3 November 2016 Submission of comments on ' Q&A on production of WFI by non-distillation methods - RO and biofilms and control strategies' (EMA/INS/489331/2016) Comments from: ISPE (International Society
More informationTraining Prospectus Public Course Dates
Training Prospectus 2018 Public Course Dates Honeyman Group Assuring Compliance in Life Science Operating extensively within the global pharmaceutical, biotech, medical device and related healthcare industries,
More information5.1.1 & Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 11/10/2017
5.1.1 & 5.1.2 V Iain Fenton-May Chairman Group 1 Methods of Preparation of Sterile Products Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 1 Methods of Preparation
More informationRisk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló
Risk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló Product Quality Microbiologist Division of Microbiology Assessment Office
More informationWFI New Ph Eur Selecting the best production option. Gordon Farquharson, July 2016
WFI New Ph Eur Selecting the best production option Gordon Farquharson, July 2016 The new WFI Monograph (0169) PRODUCTION Water for injections in bulk Water for injections in bulk is obtained from water
More informationSTERILIZATION VALIDATION IN THIS SECTION REPROCESSING VALIDATIONS FOR REUSABLE MEDICAL DEVICES. Radiation Sterilization Validation
STERILIZATION VALIDATION All sterilization processes require validation of the efficacy and reproducibility of the process. Depending on the type of sterilization, this may be accomplished by partial,
More informationDraft agreed by Quality Working Party 7 June Adopted by CHMP for release for consultation 28 June 2018
1 13 November 2018 2 EMA/CHMP/CVMP/QWP/496873/2018 3 4 Committee for Medicinal Products for Human Use (CHMP) 5 Committee for Medicinal Products for Veterinary Use (CVMP) 6 7 8 Draft Draft agreed by Quality
More informationGary Hartnett, Bausch & Lomb
What we do Mark is a very personable guy. He has a fantastic drive for results, is very customer focused, creative and leverages from a deep understanding of the pharma industry. He inspires these qualities
More informationPhase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017
Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/
More informationInspection of API Manufacturers & Update on Registration Process
Inspection of API Manufacturers & Update on Registration Process Catherine Neary, GMP Inspector GMP Conference 7 February 2017 Dublin Presentation Contents HPRA Inspection Programme for API Manufacturers
More informationQuality Assessment & GMP Similarities & Differences
Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines
More informationManual 042 Water Quality Standard
1 Purpose Manual 042 Quality Standard To describe the quality standards required for the production, distribution, use and testing of water used in the manufacture of manufactured materials. 2 Scope and
More informationGMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB
GMP for ATMP Advanced Therapy Medicinal Products 2018 Key2Compliance AB 1 Content Background and regualtory requirements GMP Walkthrough Quality Risk Management 2018 Key2Compliance AB 2 Background and
More informationDeficiencies found in Inspections and QP Responsibilities
Deficiencies found in Inspections and QP Responsibilities Ciara Turley, HPRA Inspector QP Forum, Trinity College, Dublin 25 th April 2017 Dublin Key QP Responsibilities Chapter 1, 1.4 (xv) Medicinal products
More informationAnalytical and formulation attributes
Peer reviewed article Analytical and formulation attributes in developing generic sterile injectable liquid and lyophilized drugs (part 1) Arindam Roy ARINDAM ROY 1,2 *, GURMUKH CHANANA 1 *Corresponding
More informationGetting it Right Microbial Quality Risk Management
Programme Linda Musker Quality Control North West Mark Oldcorne All Wales Pharmaceutical Quality Assurance Getting it Right Microbial Quality Risk Management Strategic Background (MAO) The Problem (LM)
More informationValidation Needs for Sterilization by Aseptic Filtration
Validation Needs for Sterilization by Aseptic Filtration DCVMN Workshop, Hyderabad, 4-8 April 2016 Ramesh Raju Associate Director - Provantage Validation Services Overview Key Regulatory and Industry guidelines
More informationQualified Persons in the Pharmaceutical Industry Study Guide
Qualified Persons in the Pharmaceutical Industry Study Guide Guide to the knowledge and practical experience required by Qualified Persons relating to pharmaceutical manufacturing in the UK February 2013
More informationGMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides
FDA cgmp cgmp Guide Drugs 21 CFR 210 cgmp Guide Drugs 21 CFR 211 cgmp Guide Medical Device 21 CFR 808, 812, 820 cgmp Guide Biologics 21 CFR 600, 606, 610 Guideline List Human Drugs Guideline List Biologics
More informationThermo Scientific HyClone WFI Quality Water. Ultra pure to meet today s rapid manufacturing advances
Thermo Scientific HyClone WFI Quality Water Ultra pure to meet today s rapid manufacturing advances What sets Thermo Scientific HyClone WFI Quality Water apart? Our cgmp ISO 9001 manufacturing facility,
More informationMaterials Management Traceability, CEPs and managing non-conforming sites
Materials Management Traceability, CEPs and managing non-conforming sites IMB Information Day, 14 th October 2010 Dr Cormac Dalton Inspector 13-Oct-10 Slide 1 Managing Supply Supply Demand Supply chain
More informationAdvancements on implementation of single use technology in vaccine manufacturing
Advancements on implementation of single use technology in vaccine manufacturing October 25 th, 2013 DCVMN Meeting Rio de Janeiro, Brazil Outline Overview of single use products Applications of single
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: MANUFACTURE OF THE FINISHED DOSAGE FORM
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/CVMP/126/95 FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: MANUFACTURE OF THE
More informationWebinar. The New EU-GMP Annex 1 draft Dupont. GOP-Innovations your Partner for Practical Training and e-learning. 8 June 2018
Webinar The New EU-GMP Annex 1 draft Dupont 8 June 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, consultant, trainer, coach 10 years
More informationGMP for ATMP should be a document annexed to standard GMP (a new Annex) and not a stand-alone document.
Leem comments on Commission proposal for Good Manufacturing Practice for Advanced Therapy Medicinal Products 1. General comments Line number(s) of the relevant text General comment
More informationSterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM
Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory
More informationEU and FDA GMP Regulations: Overview and Comparison
THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational
More informationCMC Strategy Forum Europe 2016
Science-based Development & Licensing of Combination Products Focus on High Concentration Monoclonal Antibody Solutions in Prefilled Syringes or Prefilled Pens Serge Mathonet, Sanofi Global Regulatory
More informationAseptic Process Validation
Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic
More informationComments from: 1. General comments. International Plasma Fractionation Association (IPFA) Our ref. IP
Submission of comments on Commission proposal for Good Manufacturing Practice for Advanced Therapy Medicinal Products Comments from: Name of organisation or individual International
More informationPDA: A Global. Association. Contamination Control: Particles, Bio-contamination, Aseptic manufacturing. PDA Parenteral 2014 Munich Conference
PDA Parenteral 2014 Munich Conference PDA: A Global Contamination Control: Particles, Bio-contamination, Bioburden Association and Endotoxins in Aseptic manufacturing. James Drinkwater F Ziel Head of Aseptic
More informationSupplier Assurance Program. CBE Pty Ltd
Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.
More informationGood manufacturing practices
The rules governing medicinal products in the European Union Volume 4 Good manufacturing practices Medicinal products for human and veterinary use 1998 Edition EUROPEAN COMMISSION Directorate General III
More informationRegulatory Requirements & Recent Changes, including expectations for APIs & IMPs
Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationPROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.
Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation
More informationGMP Regulations for Pharmaceutical Industry
CONTENTS Foreword... (v) Preface... (vii) CHAPTER 1 GMP Regulations for Pharmaceutical Industry 1.1 Basic Requirements of GMP... 1 1.2 Organization Pillars in cgmp... 2 a. Management Responsibilities...
More informationAvoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS
Avoid recurrent microbial contamination using trending of historical data El Azab Walid Technical Service Manager STERIS Agenda Factors influencing the cleaning and disinfection performance Recurring microbial
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, 6 February 2014 SANCO/TSE/ The received contributions together with the identity of
More informationPIC/S GMP GUIDE FOR BLOOD ESTABLISHMENTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 005-2 1 July 2004 PIC/S GMP GUIDE FOR BLOOD ESTABLISHMENTS PIC/S July 2004 Reproduction prohibited for commercial purposes.
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working
More informationCurriculum Vitae. SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone:
Curriculum Vitae SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone: 240.413.3350 Summary of Qualifications Jim has been active in the medical products industry since 1967. Jim founded a company in 1980
More informationEMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016
EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems Jan Thomsen Warsaw, November 15 th, 2016 2 Content Emprove - An Introduction Emprove for Raw and Starting Materials
More informationMicrosol4. General Purpose Decontaminant Effective Against DNA/RNA Contamination
Microsol4 All-in-One Cleaning and Disinfection Concentrate for Dilution Ready-to-Use Spray Ready-to-Use Wipes General Purpose Decontaminant Effective Against DNA/RNA Contamination Microsol 4 Microsol 4
More informationGMP for ATMPs. Ian Rees, Unit Manager Inspectorate Strategy & Innovation 4 th October 2018
GMP for ATMPs Ian Rees, Unit Manager Inspectorate Strategy & Innovation 4 th October 2018 Presentation outline MHRA Annex 2-2013 Change procedure for GMP guidelines Part IV EU & PIC/S MHRA/BP/NIBSC - standards
More informationContact details: Anna Silvani
Consultation Document Good Manufacturing Practice for Advanced Therapy Medicinal Products MolMed comments to the DG SANTE consultation on GMPs for ATMPs pursuant to Article 5 of Regulation 1394/2007. MolMed
More informationFormulated Chemistries for Critical Environments
STERIS CORPORATION Formulated Chemistries for Critical Environments Superior Cleaning Products Backed by Proven Expertise Unique in critical environments......................... AND/OR REGULATORY CLAIMS
More informationOn behalf of the PHSS Pharmaceutical and Healthcare Sciences Society (UK).
31 st March 2015 Submission of comments on ' Concept paper on the revision of annex 1 of the guidelines on good manufacturing practice manufacture of sterile medicinal products EMA/INS/GMP/735037/2014
More informationGuideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE- GENERAL Health systems and products Medicinal products quality, safety and efficacy 18 February 2010 EMA/CHMP/BWP/534898/2008 Committee for Medicinal
More informationFDA s Guidance for Industry
Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance
More informationGuidance for Aseptic Transfer Processes in the NHS: Addressing Sporicidal Issues
Guidance for Aseptic Transfer Processes in the NHS: Addressing Sporicidal Issues 1 st Edition July 2015 A report by the NHS Pharmaceutical Micro Protocols Group NHS Pharmaceutical Quality Assurance Committee
More informationNO 2 Gas Sterilization and Decontamination: Keeping Pace, from Start to Finish
NO 2 Gas Sterilization and Decontamination: Keeping Pace, from Start to Finish Evan Goulet, Ph.D., VP of Microbiology Applications Laboratory PDA Midwest: Sterility Assurance and Risk Mitigation October
More informationNew EU GMP for ATMPs vs existing GMPs pros and cons. Drew Hope Director of Quality Operations, Autolus
New EU GMP for ATMPs vs existing GMPs pros and cons Drew Hope Director of Quality Operations, Autolus Rapid implementation The EC adopted GMP requirements for ATMPs 22 NOV 2017 Comes into operation 22
More informationSurface Fungicidal Activity of Clinell Universal Wipes ~ Project Report Prepared for Gama Healthcare Ltd.
Surface Fungicidal Activity of Clinell Universal Wipes ~ Project Report Prepared for Gama Healthcare Ltd. Inspiring tomorrow s professionals Surface Fungicidal Activity of Clinell Universal Wipes Author:
More informationOutsourcing - managing risks and opportunities over which you now have less control
Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance
More informationReview article Rapports De Pharmacie 2015;1(2):46-53 ISSN:
Review article Rapports De Pharmacie 2015;1(2):46-53 ISSN: 2455-0507 ABSTRACT APPLICATION OF RISK ASSESSMENT IN PRODUCT QUALITY LIFECYCLE MANAGEMENT Subin Sankarankutty Regulatory Consultant, Health Sciences
More informationContact details: Ilaria Lucibello
Assobiotec contribution to the European Commission Consultation Document Good anufacturing Practice for Advanced Therapy edicinal Products Issued 28-Jun-2016 Assobiotec is the Italian Association for the
More informationAPI Inspections in Emerging Markets: The EDQM Experience
API Inspections in Emerging Markets: The EDQM Experience 18 October 2010 Sträter Life Science Gründungsymposium Dr Florence Benoit-Guyod, EDQM Inspector Certification of Substances Division European Directorate
More informationDisinfectant Qualification and Cleanroom Disinfection A Step by Step Workshop
Microrite, Inc. brings you this unique advanced course in ; part of Microrite s Step by Step Workshop Series Participate in the only workshop which will guide you through the process of choosing a cost
More informationAseptic Processing Current Issues & Trends
Aseptic Processing Current Issues & Trends 1 Introduction Richard M. Johnson Member, PDA for 20+ years President & CEO since 2009 Ladies and Gentlemen, I am happy to be here with you. Senhoras e Senhores,
More informationInspection Hot Topics
Inspection Hot Topics QP Forum, Trinity College Ciara Turley, Inspector, HPRA 16 th April 2015 Content Hot topics = common deficiencies Data based on 100 inspections conducted in 2014 Inspections of non-sterile
More informationWork plan for the GMP/GDP Inspectors Working Group for 2018
30 November 2017 EMA/INS/GMP/504401/2017 Inspections, Human Medicines Pharmacovigilance & Committees Division Work plan for the GMP/GDP Inspectors Working Group for 2018 Chairperson: Brendan Cuddy Adopted:
More informationPIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 010-3 1 October 2008 PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS
More informationMultiproduct ATMP Manufacturing a QP and Pharmacist s Perspective. Anne Black Assistant Director of Pharmacy - Quality Assurance
Multiproduct ATMP Manufacturing a QP and Pharmacist s Perspective Anne Black Assistant Director of Pharmacy - Quality Assurance Contents Newcastle Medicines Manufacture Transition from traditional medicines
More informationQualified Persons (IMP) Don Wallace Regional QA Pharmacist 27 th May 2014
Qualified Persons (IMP) Don Wallace Regional QA Pharmacist 27 th May 2014 Introduction EU Clinical Trials Directive 2001 came into existence in the UK in May 2004 (Part 6 Manufacture of Investigational
More informationGood Clinical Practice Inspections Expectations for Compliance with Sponsor Responsibilities, Part II
Good Clinical Practice Inspections Expectations for Compliance with Sponsor Responsibilities, Part II IMB Clinical Trials Seminar, 19 th June 2012 Ms. Sinead Curran GCP/Pharmacovigilance Inspector 22/06/2012
More informationOVIVO PHARMACEUTICAL SOLUTIONS SOLUTIONS FOR PURIFIED WATER, HIGHLY PURIFIED WATER AND WATER FOR INJECTION.
Worldwide Experts in Water Treatment SOLUTIONS FOR PURIFIED WATER, HIGHLY PURIFIED WATER AND WATER FOR INJECTION Manufactured and preassembled by Ovivo Constructed in pre-mounted, fully divided plant sections
More informationDraft Guidelines for Radiopharmacy
Draft Guidelines for Radiopharmacy In the nuclear medicine laboratories (radiopharmacies) of nuclear medicine clinics in European hospitals, quality assurance varies from non-existent to good manufacturing
More informationOverview of a sterility assurance program for PET drugs
Coalition for PET Drug Approval Radiopharmaceutical Sciences Council Overview of a sterility assurance program for PET drugs Eric Webster, PETNET Solutions Disclosures Employee of PETNET Solutions, a Siemens
More informationEU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT
1 EU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT UNDERSTAND THE PROGRESSION OF REGULATORY THINKING AND HOW TO SUCCESSFULLY IMPLEMENT THE PROPOSED CHANGES BALTIMORE, MD MAY 6TH AND 7TH, 2019 UNIVERSITY
More informationMICROBIOLOGICAL PROFILE
Evans Vanodine International plc G L O B A L H Y G I E N E S O L U T I O N S EC4 SANITISER MICROBIOLOGICAL PROFILE 1 INTRODUCTION EC4 SANITISER is a multi-surface unperfumed cleaner and disinfectant. It
More informationGuideline on the requirements for quality documentation concerning biological investigational medicinal products in clinical trials
1 2 3 23 June 2016 EMA/CHMP/BWP/534898/2008 rev. 1 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Guideline on the requirements for quality documentation concerning biological investigational
More informationResidue removal in Cleanroom Environments
Residue removal in Cleanroom Environments PDA Midwest Indianapolis Event 06 Oct 2016 Contamination Control Solutions 1/ BIO Beth Kroeger Technical Service Manager STERIS Life Sciences 4 years 24 years
More informationREUSABLE MEDICAL DEVICE VALIDATION
All sterilization processes require validation of the efficacy and reproducibility of the process. Depending on the type of sterilization, this may be accomplished by partial, sub-lethal, or repetitive
More informationLow Endotoxin Products for Critical Environments
Low Endotoxin Products for Critical Environments Contec is a leading manufacturer of contamination control products for critical cleaning in manufacturing environments worldwide. Contec s cleanroom wipes,
More informationChallenges in Commercialization of Autologous Cell Therapy Products. Bryan Silvey & Kanti Thirumoorthy Kite Quality
Challenges in Commercialization of Autologous Cell Therapy Products Bryan Silvey & Kanti Thirumoorthy Kite Quality Aspects Unique to Autologous Cell Therapy: Product Challenges Complex starting material
More informationPharmaceutical Reference Standards: Overview and Role in Global Harmonization
Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference
More informationAPI EUROPEAN GMP REQUIREMENTS. Alessio Ferrari
API EUROPEAN GMP REQUIREMENTS Alessio Ferrari SUMMARY GUIDELINES IMPLICATIONS FOR THE INDUSTRY ARTICLE 46 (F) OF DIRECTIVE 2001/83/EC PART I EU GMP Chapter 5 OFFICIAL MEASURES TO PROTECT. PROCEDURE TO
More informationIndustry Perspective on PET Manufacturing Comparison of EU and US
Standards for Imaging Endpoints and Manufacturing of PET Radiopharmaceuticals Industry Perspective on PET Manufacturing Comparison of EU and US Guidances and associated Regulations Natcher Conference Center
More informationGuidance for Industry
Guidance for Industry for the Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products Center for Drug Evaluation and Research (CDER) Center
More informationDocumenta tion and Records
Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping
More informationPlease note that these comments and the identity of the sender will be published unless a specific justified objection is received.
Ref. Ares(2015)5763462-11/12/2015 11 December 2015 Submission of comments on Annex 17: Real Time Release Testing EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary
More informationEnvironmental Monitoring of Aseptic Processing Areas - 1
Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring
More informationJeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise:
Regulatory Expertise: Pharmaceuticals: Sterile-Liquids, Non-Sterile Liquids, Solid Oral Dosage Form, Parenterals, Antibiotics, APIs/Bulk Chemicals, Creams & Ointments Medical Devices: Implantable / Active
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION ANSI-ASQ National Accreditation Board 500 Montgomery Street, Suite 625, Alexandria, VA 22314, 877-344-3044 This is to certify that Dynatec Scientific Laboratories, Inc. 11940
More informationChange Control Overview
Change Control Overview Kelly Thomas Atlantic Technical and Validation Services Copyright 2014 by Atlantic Technical and Validation Services, LLC. 1 Session Outline Discuss Regulations Governing Change
More information